This Startup Has A New Way To Quit Smoking. Will This Be The One That Works?
With $35 million in funding, Qnovia hopes its device will become the first new prescription nicotine replacement therapy in ...
Yahoo Finance23d
Qnovia set to trial smoking cessation inhaler in the US
Qnovia has received clearance from the US Food and Drug Administration (FDA) to start a clinical trial for its RespiRX nicotine inhaler as a replacement therapy for smoking. The US-based company ...
Blowing smoke: Big Tobacco is getting a whole new generation hooked on nicotine
The industry says it wants to phase out cigarettes, but are its latest innovations an honest attempt to diversify?
KLFY News 1025d
Qnovia, Inc. announces FDA clearance of IND application for lead asset RespiRx™ Nicotine Inhaler as a prescription smoking cessation therapy
The study will evaluate the pharmacokinetics, safety and tolerability of the RespiRx ™ Nicotine Inhaler compared to Nicotrol ® Inhaler and combustible cigarettes - RICHMOND, Va., Oct. 1 ...
Medscape4d
Smoking Cessation or Reduction with Nicotine Replacement Therapy: A Placebo-controlled Double Blind Trial with Nicotine Gum and Inhaler
Background: Even with effective smoking cessation medications, many smokers are unable to abruptly stop using tobacco. This finding has increased interest in smoking reduction as an interim step ...